about
Can reactive school closures help critical care provision during the current influenza pandemic?Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation.Different transmission patterns in the early stages of the influenza A(H1N1)v pandemic: a comparative analysis of 12 European countries.The Early Transmission Dynamics of H1N1pdm Influenza in the United Kingdom.Assessing the efficiency of catch-up campaigns for the introduction of pneumococcal conjugate vaccine: a modelling study based on data from PCV10 introduction in Kilifi, KenyaAssessing optimal target populations for influenza vaccination programmes: an evidence synthesis and modelling study.Temporal Changes in Ebola Transmission in Sierra Leone and Implications for Control Requirements: a Real-time Modelling StudyPrediction of serotypes causing invasive pneumococcal disease in unvaccinated and vaccinated populations.Evaluation of the benefits and risks of introducing Ebola community care centers, Sierra LeoneThe serotype distribution among healthy carriers before vaccination is essential for predicting the impact of pneumococcal conjugate vaccine on invasive disease.The Potential for Reducing the Number of Pneumococcal Conjugate Vaccine Doses While Sustaining Herd Immunity in High-Income Countries.Extending the elderly- and risk-group programme of vaccination against seasonal influenza in England and Wales: a cost-effectiveness study.The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison StudyEbola virus disease in the Democratic Republic of the Congo, 1976-2014Measuring the impact of Ebola control measures in Sierra Leone.Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical modelsAge-dependent prevalence of nasopharyngeal carriage of streptococcus pneumoniae before conjugate vaccine introduction: a prediction model based on a meta-analysisSustained reduction in vaccine-type invasive pneumococcal disease despite waning effects of a catch-up campaign in Kilifi, Kenya: A mathematical model based on pre-vaccination data.Early indication for a reduced burden of radiologically confirmed pneumonia in children following the introduction of routine vaccination against Haemophilus influenzae type b in Nha Trang, Vietnam.The Efficacy and Duration of Protection of Pneumococcal Conjugate Vaccines Against Nasopharyngeal Carriage: A Meta-regression Model.Airport screening for Ebola.Exploring the role of competition induced by non-vaccine serotypes for herd protection following pneumococcal vaccination.The impact of specific and non-specific immunity on the ecology of Streptococcus pneumoniae and the implications for vaccination.Long term trends introduce a potential bias when evaluating the impact of the pneumococcal conjugate vaccination programme in England and Wales.Trends in serotypes and sequence types among cases of invasive pneumococcal disease in Scotland, 1999-2010.Within-host dynamics shape antibiotic resistance in commensal bacteriaSerostatus Testing & Dengue Vaccine Cost-Benefit ThresholdsInfant contact in day-care centres in Vietnam: A cross-sectional study to understand infant infection risk.Feasibility of controlling COVID-19 outbreaks by isolation of cases and contactsEffectiveness of airport screening at detecting travellers infected with 2019-nCoVInterventions targeting air travellers early in the pandemic may delay local outbreaks of SARS-CoV-2Patterns of human social contact and contact with animals in Shanghai, ChinaAssociations between ethnicity, social contact, and pneumococcal carriage three years post-PCV10 in FijiEstimating the proportion of vaccine-induced hospitalized dengue cases among Dengvaxia vaccinees in the PhilippinesSerostatus testing and dengue vaccine cost-benefit thresholdsThe effect of inter-city travel restrictions on geographical spread of COVID-19: Evidence from Wuhan, ChinaEstimating the contribution of different age strata to vaccine serotype pneumococcal transmission in the pre vaccine era: a modelling study
P50
Q30383805-C512D855-29A7-4AF5-95B1-6809023F3EF5Q30384775-7FD0C929-3DE0-490D-8A92-3A0038A4B6B6Q30403272-C59A0E09-50F0-44B4-9219-9690EB40A7A4Q33520455-6BAEF99E-43A0-4B47-92AE-2D666CAFAF31Q33776584-3D5358D5-D2FC-409E-B9AA-7822FF34CAE7Q35014268-D7E3C397-71DB-4541-AD29-B08A613305F6Q35117466-43767B84-7B12-461E-8BD7-4F1AEC1B5D11Q35124898-1BB59A09-9BFD-43F3-8309-3735CE1F00B8Q35130385-52CAC355-B04F-4631-94AB-7B3A7942D048Q35603351-3517AE6E-006E-4EAB-879B-06C6470717C9Q35658460-A63B4318-B2A5-44FC-96E5-E55DE8C28D55Q35803937-441C2767-5737-4940-B971-8FA17002F6BCQ36206692-4DC6E199-2993-4485-B6A6-14540021C090Q36238123-AE1AFBBE-D79B-454C-8AF4-ACEFA2A239A0Q36305992-C828A9E5-ED05-4D2A-AA7C-F1F7A34FBF68Q36492529-44E00279-A6A9-407A-BE2D-A0FA47F9BC92Q37509931-692DA453-0937-40C2-AEC0-1BDB9DCAF80CQ38669404-6DB88BB7-650D-47F0-9B91-C7AABEA9C015Q39005740-9ADA282B-21B7-4152-8496-9F3D66439C8DQ39164516-B10591D9-E605-407E-A288-759CA19BA77EQ44093980-8CA8DFCF-A346-4133-9168-E8CA4C32AAF6Q47115918-B8CCA4AD-BFE7-4AD2-9BB1-6317AFB955A1Q51157834-DE6506F4-762D-402A-B06F-4491B829E717Q51164443-D0D8266F-1A0B-455D-9DA6-CD223662280AQ51193840-1B4CDA83-FB41-47CE-81A5-FD0E38C9961BQ61910249-0D547939-D3DE-47E0-87B9-A2B0DD256F55Q63683223-04597456-365D-44FD-86D7-BDEF0DE574FEQ64967683-AC5CA69B-5655-49E4-A30D-2E9BED3BAD35Q87191021-751b30ba-4341-8fff-f832-f7179440ee7eQ88973761-D6A58A09-19BF-47CF-94E5-7633814B3EA2Q88974238-781DC60F-B5BA-4E46-A7E0-A4635598B677Q90884541-7A89C169-4130-4FAF-9A36-E7B3BD562186Q91022260-91DDC4A7-EB2B-4316-83C0-F63F408004A5Q91794015-3E634EF9-1C8D-4A8E-96DD-879305A911EDQ92732496-D3985C7E-9515-4129-8EA3-1247322FD7EAQ95600592-3FBA9589-86E1-496F-93EB-56B13CECAEC2Q96227805-94D86FF8-727E-401D-BAB2-DD260A381DD2
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Stefan Flasche
@ast
Stefan Flasche
@en
Stefan Flasche
@es
Stefan Flasche
@nl
Stefan Flasche
@sl
type
label
Stefan Flasche
@ast
Stefan Flasche
@en
Stefan Flasche
@es
Stefan Flasche
@nl
Stefan Flasche
@sl
prefLabel
Stefan Flasche
@ast
Stefan Flasche
@en
Stefan Flasche
@es
Stefan Flasche
@nl
Stefan Flasche
@sl
P106
P1153
36096719400
P21
P31
P496
0000-0002-5808-2606